Study the quality of life and anxiety in patients with myasthenia (clinical-parachlinal comparison)
DOI:
https://doi.org/10.15587/2519-4798.2018.127557Keywords:
myasthenia, anxiety, antibodies to acetylcholine receptors, quality of lifeAbstract
Aim of the research: To investigate the level of anxiety in adult patients with myasthenia.
Materials and methods. An in-depth clinical-neurological, immunological (detection of antibodies to acetylcholine and / or muscle-specific tyrosine kinase receptors) examination, testing according to MGQoL-15 scale, and Spielberg-Khanin anxiety scale of 96 patients (56 women and 40 men) with myasthenia (71 - with generalized, 25 - with an ophthalmologic form, respectively) were done.
Results. Antibodies to acetylcholine receptors were detected in 57 (80.3 %) of 71 patients with generalized form and in 13 (52 %) of 25 patients with ophthalmic myasthenia, antibodies to muscle-specific tyrosine kinase in 6 (8.5 %) of 71 patients with generalized form. In the case of an ophthalmic form, these antibodies were not detected. In 8 (11.3 %) out of 71 patients with generalized myasthenia and in 12 (48.0 %) out of 25 patients with ophthalmic form of myasthenia antibodies to acetylcholine receptors and muscle-specific tyrosine kinase were not detected.
When the MGQoL-15 scale was used, the average quality of life was 10.34 ± 9.4 points (ranging from 0 to 31).
In assessing of situational anxiety, a moderate level of anxiety was detected in 44 patients, high – in 24 patients, while the low level of anxiety had 28 people. Patients with an ophthalmic form of myasthenia (class I by MGFA) are significantly more likely to have a low level of anxiety (p <0.05). The moderate level of situational anxiety was significantly more frequently recorded in patients with myasthenia class III by MGFA (moderate form), and high level - in patients with myasthenia class IV by MGFA (expressed form). In patients with a low level of situational anxiety, the average duration of the disease was significantly lower (p <0.05).
When comparing the quality of life in patients with myasthenia with the MGQoL-15 scale and the level of situational anxiety with the Spielberg-Khanin scale, there was a significant negative impact of increased anxiety on quality of life (r = -0.24, p = 0.01)
Conclusions. The quality of life of patients with myasthenia and the level of anxiety disorders do not depend on the immunological subtype of the disease. The quality of life of patients with myasthenia is largely dependent on the degree of clinical manifestations of the disease. The increased level of situational anxiety reliably reduces the quality of life
References
- Kulikova, S. L. (2014). Antitela k atsetilholinovyim retseptoram v diagnostike razlichnyih form miastenii. Nevrologiya i neyrohirurgiya Vostochnaya Evropa, 1 (21), 73–82.
- Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Illa, I., Harms, L. et. al. (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology, 17 (7), 893–902. doi: 10.1111/j.1468-1331.2010.03019.x
- Shkolnik, V. M., Kalbus, A. I., Baranenko, A. N., Pogorelov, A. V. (2014). Miasteniya: sovremennyie podhodyi k diagnostike i lecheniyu. Ukrainskyi nevrolohichnyi zhurnal, 2, 12–17.
- Shkolnik, V. M., Kalbus, A. I., Shulga, O. D. (2010). Miasteniya: chto nam izvestno segodnya? Zdorovia Ukrainy (nevrolohiia, psykhiatriia, psykhoterapiya), 3 (14), 10–11.
- Shulga, O. D., Kalbus, A. I., Shulga, L. A. (2010). Miasteniya. Neyron Revyu, 2, 13–20.
- Kulaksizoglu, I. B. (2007). Mood and Anxiety Disorders in Patients with Myasthenia Gravis. CNS Drugs, 21 (6), 473–481. doi: 10.2165/00023210-200721060-00004
- Aysal, F., Karamustafalioğlu, O., Özçelik, B. et. al. (2013). The relationship of symptoms of anxiety and depression with disease severity and treatment modality in myasthenia gravis: a cross-sectional study. Archives of Neuropsychiatry, 50 (4), 295–300. doi: 10.4274/npa.y5611
- Uyaroğlu F. G., Bilgin S., Keleş E. H., Zorlu Y. (2016). Anxiety And Depression Symptoms In Patients With Generalized Myasthenia Gravis. The Journal of Tepecik Education and Research Hospital, 26 (2), 97–103. doi: 10.5222/terh.2016.097
- Suzuki, Y., Utsugisawa, K., Suzuki, S., Nagane, Y., Masuda, M., Kabasawa, C. et. al. (2011). Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open, 1 (2), e000313–e000313. doi: 10.1136/bmjopen-2011-000313
- Blum, S., Lee, D., Gillis, D., McEniery, D. F., Reddel, S., McCombe, P. (2015). Clinical features and impact of myasthenia gravis disease in Australian patients. Journal of Clinical Neuroscience, 22 (7), 1164–1169. doi: 10.1016/j.jocn.2015.01.022
- Kulkantrakorn, K., Sawanyawisuth, K., Tiamkao, S. (2010). Factors correlating quality of life in patients with myasthenia gravis. Neurological Sciences, 31 (5), 571–573. doi: 10.1007/s10072-010-0285-6
- Padua, L., Evoli, A., Aprile, I., Caliandro, P., Mazza, S., Padua, R., Tonali, P. (2001). Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurological Sciences, 22 (5), 363–369. doi: 10.1007/s100720100066
- Oliveira, E. F., Nacif, S. R., Urbano, J. J., Silva, A. S., Oliveira, C. S., Perez, E. A. et. al. (2017). Sleep, lung function, and quality of life in patients with myasthenia gravis: A cross-sectional study. Neuromuscular Disorders, 27 (2), 120–127. doi: 10.1016/j.nmd.2016.11.015
- Yang, Y., Zhang, M., Guo, J., Ma, S., Fan, L., Wang, X. et. al. (2015). Quality of life in 188 patients with myasthenia gravis in China. International Journal of Neuroscience, 126 (5), 455–462. doi: 10.3109/00207454.2015.1038712
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Oleksandr Kalbus
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
